Does SUNITINIB MALATE Cause Hyperkeratosis? 170 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 170 reports of Hyperkeratosis have been filed in association with SUNITINIB MALATE (Sunitinib malate). This represents 0.8% of all adverse event reports for SUNITINIB MALATE.
170
Reports of Hyperkeratosis with SUNITINIB MALATE
0.8%
of all SUNITINIB MALATE reports
9
Deaths
53
Hospitalizations
How Dangerous Is Hyperkeratosis From SUNITINIB MALATE?
Of the 170 reports, 9 (5.3%) resulted in death, 53 (31.2%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Hyperkeratosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SUNITINIB MALATE. However, 170 reports have been filed with the FAERS database.
What Other Side Effects Does SUNITINIB MALATE Cause?
Death (4,385)
Diarrhoea (3,044)
Fatigue (2,865)
Nausea (2,032)
Neoplasm progression (1,920)
Disease progression (1,745)
Decreased appetite (1,676)
Asthenia (1,651)
Vomiting (1,331)
Dysgeusia (1,226)
What Other Drugs Cause Hyperkeratosis?
CABOZANTINIB S-MALATE (411)
ADALIMUMAB (332)
ETANERCEPT (168)
SORAFENIB (150)
METHOTREXATE (149)
VEMURAFENIB (145)
REGORAFENIB (136)
RIPRETINIB (124)
RITUXIMAB (121)
TOCILIZUMAB (103)
Which SUNITINIB MALATE Alternatives Have Lower Hyperkeratosis Risk?
SUNITINIB MALATE vs SUTENT
SUNITINIB MALATE vs SUTIMLIMAB-JOME
SUNITINIB MALATE vs SUVOREXANT
SUNITINIB MALATE vs SUZETRIGINE
SUNITINIB MALATE vs SYMBICORT